• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 324-338 of 1,115 results

1009 Exhibit: Dixon et al, Opinion 2009

Document IPR2024-00260, No. 1009 Exhibit - Dixon et al, Opinion 2009 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1014 Exhibit: Certified Prosecution History of US Patent No 11,253,572 Part 2

Document IPR2024-00260, No. 1014-2 Exhibit - Certified Prosecution History of US Patent No 11,253,572 Part 2 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1044 Exhibit: NIH DR, Sept 2015

Document IPR2024-00260, No. 1044 Exhibit - NIH DR, Sept 2015 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1025 Exhibit: ClinicalTrialsgov Background

Document IPR2024-00260, No. 1025 Exhibit - ClinicalTrialsgov Background (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1042 Exhibit: US Patent No 9,254,338 “’338 patent”

Document IPR2024-00260, No. 1042 Exhibit - US Patent No 9,254,338 “’338 patent” (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1047 Exhibit: Rudge 2007

Document IPR2024-00260, No. 1047 Exhibit - Rudge 2007 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1032 Exhibit: Randolph and Jones, “Surfactant Protein Interactions,” , 2002

Document IPR2024-00260, No. 1032 Exhibit - Randolph and Jones, “Surfactant Protein Interactions,” , 2002 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1008 Exhibit: Apotex Petition for IPR 2022 01524 Paper 1

Document IPR2024-00260, No. 1008 Exhibit - Apotex Petition for IPR 2022 01524 Paper 1 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1012 Exhibit: Mylan v Regeneron, IPR2022 01225 Paper 21 Institution Decision

Document IPR2024-00260, No. 1012 Exhibit - Mylan v Regeneron, IPR2022 01225 Paper 21 Institution Decision (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1018 Exhibit: Elman 2010 Randomized Trial

Document IPR2024-00260, No. 1018 Exhibit - Elman 2010 Randomized Trial (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1031 Exhibit: Do DV et al, DA VINCI Study, May 5, 2011

Document IPR2024-00260, No. 1031 Exhibit - Do DV et al, DA VINCI Study, May 5, 2011 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1006 Exhibit: Regeneron December 2010 Press Release

Document IPR2024-00260, No. 1006 Exhibit - Regeneron December 2010 Press Release (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1033 Exhibit: Fraser et al, Journal of Clinical Endocrinology and Metabolism, Feb 2...

Document IPR2024-00260, No. 1033 Exhibit - Fraser et al, Journal of Clinical Endocrinology and Metabolism, Feb 2005 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1059 Exhibit: Eylea Label 2011

Document IPR2024-00260, No. 1059 Exhibit - Eylea Label 2011 (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

1043 Exhibit: WO 2012097019A1 “Yancopoulos PCT Application”

Document IPR2024-00260, No. 1043 Exhibit - WO 2012097019A1 “Yancopoulos PCT Application” (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 22 23 24 25 26 ... >>